False-positive recall is a recognized disadvantage of mammographic breast screening, and the rate of such recalls may be higher in younger women, potentially limiting the value of screening below age 50.
Johns, L. E., & Moss, S. M. (2010). False-positive results in the randomized controlled trial of mammographic screening from age 40 (“age” trial). Cancer Epidemiology Biomarkers and Prevention, 19(11), 2758–2764. https://doi.org/10.1158/1055-9965.EPI-10-0623